US Bancorp’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.56K Hold
2,980
﹤0.01% 3547
2025
Q1
$3.46K Sell
2,980
-3,076
-51% -$3.57K ﹤0.01% 3740
2024
Q4
$7.69K Buy
6,056
+1,630
+37% +$2.07K ﹤0.01% 3505
2024
Q3
$15.1K Buy
4,426
+3,223
+268% +$11K ﹤0.01% 3218
2024
Q2
$5.62K Buy
1,203
+78
+7% +$364 ﹤0.01% 3465
2024
Q1
$8.35K Buy
1,125
+309
+38% +$2.29K ﹤0.01% 3384
2023
Q4
$8.27K Sell
816
-888
-52% -$9K ﹤0.01% 3361
2023
Q3
$13.3K Sell
1,704
-87
-5% -$679 ﹤0.01% 3049
2023
Q2
$14.7K Sell
1,791
-451
-20% -$3.71K ﹤0.01% 3086
2023
Q1
$16.3K Buy
2,242
+1,098
+96% +$7.96K ﹤0.01% 3086
2022
Q4
$10.1K Sell
1,144
-1,199
-51% -$10.6K ﹤0.01% 3282
2022
Q3
$29K Sell
2,343
-767
-25% -$9.49K ﹤0.01% 2824
2022
Q2
$37K Sell
3,110
-9,589
-76% -$114K ﹤0.01% 2732
2022
Q1
$243K Buy
12,699
+1,520
+14% +$29.1K ﹤0.01% 1855
2021
Q4
$296K Sell
11,179
-8,508
-43% -$225K ﹤0.01% 1793
2021
Q3
$809K Buy
19,687
+9,515
+94% +$391K ﹤0.01% 1297
2021
Q2
$577K Sell
10,172
-2,961
-23% -$168K ﹤0.01% 1474
2021
Q1
$551K Buy
13,133
+4,000
+44% +$168K ﹤0.01% 1442
2020
Q4
$641K Buy
9,133
+5,002
+121% +$351K ﹤0.01% 1314
2020
Q3
$116K Sell
4,131
-2,831
-41% -$79.5K ﹤0.01% 2010
2020
Q2
$205K Sell
6,962
-14,148
-67% -$417K ﹤0.01% 1738
2020
Q1
$419K Buy
21,110
+500
+2% +$9.92K ﹤0.01% 1288
2019
Q4
$610K Buy
20,610
+18,865
+1,081% +$558K ﹤0.01% 1268
2019
Q3
$39K Buy
1,745
+545
+45% +$12.2K ﹤0.01% 2584
2019
Q2
$30K Sell
1,200
-230
-16% -$5.75K ﹤0.01% 2738
2019
Q1
$35K Buy
1,430
+480
+51% +$11.7K ﹤0.01% 2645
2018
Q4
$21K Hold
950
﹤0.01% 2789
2018
Q3
$30K Sell
950
-200
-17% -$6.32K ﹤0.01% 2783
2018
Q2
$41K Sell
1,150
-471
-29% -$16.8K ﹤0.01% 2660
2018
Q1
$54K Buy
1,621
+821
+103% +$27.4K ﹤0.01% 2559
2017
Q4
$25K Hold
800
﹤0.01% 2853
2017
Q3
$19K Buy
+800
New +$19K ﹤0.01% 2906